Neopterin is a biomarker of chronic heart failure (review of modern literature)
| Autor: | Amina M. Alieva, Tatiana V. Pinchuk, Kira V. Voronkova, Lidiia M. Shnakhova, Olga A. Ettinger, Madina F. Akhmedova, Ramiz K. Valiev, Marina R. Kalova, Elvina T. Gasanova, Igor G. Nikitin |
|---|---|
| Jazyk: | ruština |
| Rok vydání: | 2021 |
| Předmět: | |
| Zdroj: | Consilium Medicum, Vol 23, Iss 10, Pp 756-759 (2021) |
| Druh dokumentu: | article |
| ISSN: | 2075-1753 2542-2170 20751753 |
| DOI: | 10.26442/20751753.2021.10.201113 |
| Popis: | Inflammation plays a role in the pathogenesis of heart failure. Neopterin, pteridine, synthesized mainly by activated macrophages, is a marker of inflammation, activation of the immune system, and an active participant in cardiovascular disease. Measuring neopterin levels can help track the evolution of specific inflammatory conditions. In addition, neopterin was associated with cardiac dysfunction after cardiac surgery and improved the accuracy of predicting the risk of postoperative cardiac dysfunction. In this review, we provide current insights into neopterin and its relationship to heart failure. |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|